These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31308487)

  • 21. Integrative analysis of copy number and gene expression data identifies potential oncogenic drivers that promote mammary tumor recurrence.
    Jones RA; Moorehead RA
    Genes Chromosomes Cancer; 2019 Jun; 58(6):381-391. PubMed ID: 30597648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer.
    Joanito I; Wirapati P; Zhao N; Nawaz Z; Yeo G; Lee F; Eng CLP; Macalinao DC; Kahraman M; Srinivasan H; Lakshmanan V; Verbandt S; Tsantoulis P; Gunn N; Venkatesh PN; Poh ZW; Nahar R; Oh HLJ; Loo JM; Chia S; Cheow LF; Cheruba E; Wong MT; Kua L; Chua C; Nguyen A; Golovan J; Gan A; Lim WJ; Guo YA; Yap CK; Tay B; Hong Y; Chong DQ; Chok AY; Park WY; Han S; Chang MH; Seow-En I; Fu C; Mathew R; Toh EL; Hong LZ; Skanderup AJ; DasGupta R; Ong CJ; Lim KH; Tan EKW; Koo SL; Leow WQ; Tejpar S; Prabhakar S; Tan IB
    Nat Genet; 2022 Jul; 54(7):963-975. PubMed ID: 35773407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between genetic alterations and prognosis in sporadic colorectal cancer.
    Chang SC; Lin JK; Yang SH; Wang HS; Li AF; Chi CW
    Int J Cancer; 2006 Apr; 118(7):1721-7. PubMed ID: 16231316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization.
    Sawada T; Yamamoto E; Suzuki H; Nojima M; Maruyama R; Shioi Y; Akasaka R; Kamimae S; Harada T; Ashida M; Kai M; Adachi Y; Yamamoto H; Imai K; Toyota M; Itoh F; Sugai T
    Genes Chromosomes Cancer; 2013 Feb; 52(2):140-9. PubMed ID: 23073979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
    Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
    Elife; 2020 Jan; 9():. PubMed ID: 31939734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.
    Mouradov D; Sloggett C; Jorissen RN; Love CG; Li S; Burgess AW; Arango D; Strausberg RL; Buchanan D; Wormald S; O'Connor L; Wilding JL; Bicknell D; Tomlinson IP; Bodmer WF; Mariadason JM; Sieber OM
    Cancer Res; 2014 Jun; 74(12):3238-47. PubMed ID: 24755471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LOH and copy neutral LOH (cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability.
    Melcher R; Hartmann E; Zopf W; Herterich S; Wilke P; Müller L; Rosler E; Kudlich T; Al-Taie O; Rosenwald A; Katzenberger T; Scholtka B; Seibold S; Rogoll D; Scheppach W; Scheurlen M; Lührs H
    Carcinogenesis; 2011 Apr; 32(4):636-42. PubMed ID: 21297112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The consensus molecular subtypes of colorectal cancer.
    Guinney J; Dienstmann R; Wang X; de Reyniès A; Schlicker A; Soneson C; Marisa L; Roepman P; Nyamundanda G; Angelino P; Bot BM; Morris JS; Simon IM; Gerster S; Fessler E; De Sousa E Melo F; Missiaglia E; Ramay H; Barras D; Homicsko K; Maru D; Manyam GC; Broom B; Boige V; Perez-Villamil B; Laderas T; Salazar R; Gray JW; Hanahan D; Tabernero J; Bernards R; Friend SH; Laurent-Puig P; Medema JP; Sadanandam A; Wessels L; Delorenzi M; Kopetz S; Vermeulen L; Tejpar S
    Nat Med; 2015 Nov; 21(11):1350-6. PubMed ID: 26457759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copy number abnormalities in sporadic canine colorectal cancers.
    Tang J; Le S; Sun L; Yan X; Zhang M; Macleod J; Leroy B; Northrup N; Ellis A; Yeatman TJ; Liang Y; Zwick ME; Zhao S
    Genome Res; 2010 Mar; 20(3):341-50. PubMed ID: 20086242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refining colorectal cancer classification and clinical stratification through a single-cell atlas.
    Khaliq AM; Erdogan C; Kurt Z; Turgut SS; Grunvald MW; Rand T; Khare S; Borgia JA; Hayden DM; Pappas SG; Govekar HR; Kam AE; Reiser J; Turaga K; Radovich M; Zang Y; Qiu Y; Liu Y; Fishel ML; Turk A; Gupta V; Al-Sabti R; Subramanian J; Kuzel TM; Sadanandam A; Waldron L; Hussain A; Saleem M; El-Rayes B; Salahudeen AA; Masood A
    Genome Biol; 2022 May; 23(1):113. PubMed ID: 35538548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype.
    Kwon Y; Park M; Jang M; Yun S; Kim WK; Kim S; Paik S; Lee HJ; Hong S; Kim TI; Min B; Kim H
    Oncotarget; 2017 Jun; 8(24):39367-39381. PubMed ID: 28455965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8.
    De Bortoli M; Castellino RC; Lu XY; Deyo J; Sturla LM; Adesina AM; Perlaky L; Pomeroy SL; Lau CC; Man TK; Rao PH; Kim JY
    BMC Cancer; 2006 Sep; 6():223. PubMed ID: 16968546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amplifications of NCOA3 gene in colorectal cancers in a Chinese population.
    Li Z; Fang ZY; Ding Y; Yao WT; Yang Y; Zhu ZQ; Wang W; Zhang QX
    World J Gastroenterol; 2012 Feb; 18(8):855-60. PubMed ID: 22371647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular differences in the microsatellite stable phenotype between left-sided and right-sided colorectal cancer.
    Takahashi Y; Sugai T; Habano W; Ishida K; Eizuka M; Otsuka K; Sasaki A; Takayuki Matsumoto ; Morikawa T; Unno M; Suzuki H
    Int J Cancer; 2016 Dec; 139(11):2493-501. PubMed ID: 27509333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry.
    Li X; Larsson P; Ljuslinder I; Ling A; Löfgren-Burström A; Zingmark C; Edin S; Palmqvist R
    Pathol Res Pract; 2021 Apr; 220():153379. PubMed ID: 33721619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung Adenocarcinoma.
    Han X; Tan Q; Yang S; Li J; Xu J; Hao X; Hu X; Xing P; Liu Y; Lin L; Gui L; Qin Y; Yang J; Liu P; Wang X; Dai W; Lin D; Lin H; Shi Y
    Front Oncol; 2019; 9():556. PubMed ID: 31448219
    [No Abstract]   [Full Text] [Related]  

  • 37. [The significance and characteristics of chromosomal abnormalities in patients with microsatellite and chromosome stable colorectal carcinoma].
    Xie D; Wu HX; Liu YD; Zeng SD; Lin F
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):11-5. PubMed ID: 17403304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer.
    Sefrioui D; Vermeulin T; Blanchard F; Chapusot C; Beaussire L; Armengol-Debeir L; Sesboué R; Gangloff A; Hebbar M; Copin MC; Houivet E; Schwarz L; Clatot F; Tuech JJ; Bénichou J; Martin L; Bouvier AM; Sabourin JC; Sarafan-Vasseur N; Frébourg T; Lepage C; Michel P; Di Fiore F
    Int J Cancer; 2017 Apr; 140(7):1653-1661. PubMed ID: 28006840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour break load is a biologically relevant feature of genomic instability with prognostic value in colorectal cancer.
    Lakbir S; Lahoz S; Cuatrecasas M; Camps J; Glas RA; Heringa J; Meijer GA; Abeln S; Fijneman RJA
    Eur J Cancer; 2022 Dec; 177():94-102. PubMed ID: 36334560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.